business
Claim Forest mulling Elan bid
Forest Laboratories, the speciality drugmaker that counts investor Carl Icahn as a major shareholder, is among a handful of companies interested in bidding for Irish biotech firm Elan, sources claim.
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC